Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.51EUR
−45.59 MEUR
201.57 MEUR
41.86 M
About ATRYS HEALTH, S.A.
Sector
Industry
CEO
Isabel Lozano Fernandez
Website
Headquarters
Barcelona
Founded
2007
ISIN
ES0105148003
FIGI
BBG00DF55HM6
Atrys Health SA is a biomedical company, which engages in the research and development of diagnostic services. It offers medical treatment for oncology, radiology, cardiology, ophthalmology, and dermatology. The firm operates through the following segments: Telediagnosis, Diagnosis, Radiotherapy, Research & Development, and Smart & Big Data. The company was founded by Carlos Cordón-Cardó on January 4, 2007 and is headquartered in Barcelona, Spain.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ATRY is 3.15 EUR — it has increased by 0.32% in the past 24 hours. Watch ATRYS HEALTH, S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BME exchange ATRYS HEALTH, S.A. stocks are traded under the ticker ATRY.
ATRY stock has fallen by −1.56% compared to the previous week, the month change is a −9.20% fall, over the last year ATRYS HEALTH, S.A. has showed a −13.22% decrease.
We've gathered analysts' opinions on ATRYS HEALTH, S.A. future price: according to them, ATRY price has a max estimate of 6.90 EUR and a min estimate of 6.18 EUR. Watch ATRY chart and read a more detailed ATRYS HEALTH, S.A. stock forecast: see what analysts think of ATRYS HEALTH, S.A. and suggest that you do with its stocks.
ATRY reached its all-time high on Aug 30, 2021 with the price of 11.25 EUR, and its all-time low was 1.28 EUR and was reached on Aug 29, 2017. View more price dynamics on ATRY chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ATRY stock is 2.54% volatile and has beta coefficient of 0.93. Track ATRYS HEALTH, S.A. stock price on the chart and check out the list of the most volatile stocks — is ATRYS HEALTH, S.A. there?
Yes, you can track ATRYS HEALTH, S.A. financials in yearly and quarterly reports right on TradingView.
ATRYS HEALTH, S.A. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
ATRY net income for the last half-year is −16.48 M EUR, while the previous report showed −22.59 M EUR of net income which accounts for 27.04% change. Track more ATRYS HEALTH, S.A. financial stats to get the full picture.
No, ATRY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 4, 2024, the company has 2.06 K employees. See our rating of the largest employees — is ATRYS HEALTH, S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ATRYS HEALTH, S.A. EBITDA is 27.63 M EUR, and current EBITDA margin is 16.60%. See more stats in ATRYS HEALTH, S.A. financial statements.
Like other stocks, ATRY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ATRYS HEALTH, S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ATRYS HEALTH, S.A. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ATRYS HEALTH, S.A. stock shows the sell signal. See more of ATRYS HEALTH, S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.